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Synaptic vesicles contain small 
ribonucleic acids (sRNAs) including 
transfer RNA fragments (trfRNA) 
and microRNAs (miRNA)
Huinan Li, Cheng Wu, Rodolfo Aramayo, Matthew S. Sachs & Mark L. Harlow
Synaptic vesicles (SVs) are neuronal presynaptic organelles that load and release neurotransmitter 
at chemical synapses. In addition to classic neurotransmitters, we have found that synaptic vesicles 
isolated from the electric organ of Torpedo californica, a model cholinergic synapse, contain small 
ribonucleic acids (sRNAs), primarily the 5′ ends of transfer RNAs (tRNAs) termed tRNA fragments 
(trfRNAs). To test the evolutionary conservation of SV sRNAs we examined isolated SVs from the 
mouse central nervous system (CNS). We found abundant levels of sRNAs in mouse SVs, including 
trfRNAs and micro RNAs (miRNAs) known to be involved in transcriptional and translational 
regulation. This discovery suggests that, in addition to inducing changes in local dendritic excitability 
through the release of neurotransmitters, SVs may, through the release of specific trfRNAs and 
miRNAs, directly regulate local protein synthesis. We believe these findings have broad implications 
for the study of chemical synaptic transmission.
Multiple downstream events occur upon the activity-dependent release of neurotransmitter at chemical 
synapses. Most obviously, the presynaptic release of neurotransmitter leads to a stereotypic electrical 
change across a postsynaptic cell membrane. Thus at vertebrate neuromuscular junctions the release of 
acetylcholine leads to the activation of nicotinic acetylcholine receptors on the muscle membrane, mem-
brane depolarization and subsequent muscle contraction1–3. More dynamically, the presynaptic release of 
neurotransmitter coupled with coincident local postsynaptic membrane depolarization leads to a change 
in synaptic physiology that can persist for minutes, hours or days4. These long term changes have been 
best characterized at central nervous system (CNS) synapses, and can lead to long term potentiation 
(LTP) or depression (LTD) of the synaptic coupling between the two cells. In the short-term (minutes) 
both LTP and LTD rely upon changes in calcium, but for these synaptic changes to be consolidated for 
the long-term (hours and days) requires, in addition to calcium influx, local protein synthesis5.
Local protein synthesis at the synapse requires a host of mRNAs, translation factors, and ribosomes6–9. 
In addition, it is suspected that microRNA (miRNA) and other non-coding RNA (ncRNA) that include, 
but are not restricted to, endogenous small interfering RNA (esiRNA), piwi-interacting RNA (piRNA), 
antisense and long-ncRNA, play a key role in regulating translation10. Mechanistically, the release of 
neurotransmitter presynaptically has been thought to indirectly drive the selective control of postsynaptic 
protein synthesis through activity-based modulation of calcium11.
We hypothesized that the presynaptic terminal might play a more direct role in the regulation of 
postsynaptic transcription and translation. Previous studies have identified sRNAs that are associated 
with synaptosomes, as well as sRNAs that are released from and taken into synaptosomes and sRNAs 
that associate with SV fractions12,13. As a first step to test the hypothesis that the presynaptic termi-
nal might play a more active role in local protein synthesis, we looked for the presence of, and ulti-
mately sequenced, small molecule RNAs (sRNAs) that not only associate with synaptosomes and SVs, 
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but localize within the SVs. We first chose SVs isolated from the electroplaques of Torpedo californica, a 
classic peripheral nervous system (PNS) preparation that provides an abundance of cholinergic synaptic 
vesicles from one class of motor neuron14. We treated the SVs with RNase to remove any exogenous cyto-
plasmic RNA from the preparation, and after RNA extraction, found an abundance of sRNAs protected 
from degradation. Sequencing of the sRNAs derived from affinity purified SVs revealed the presence of 5′ 
tRNA fragments, with a 5′ -fragment of glutamyl-tRNA (tRNAGlu) sequence constituting the most abun-
dant of the sequences. We verified by northern blot that the 5′ fragments were not a result of the RNase 
treatment of the vesicles, and that the fragments were protected from degradation in the absence of (but 
not the presence of) detergent. In situ hybridization of the most abundant fragment sequence confirmed 
the presence of the fragment in the axons and presynaptic terminals of the electroplaque. We extended 
the results to SVs isolated from the mouse CNS. As with the electroplaque, we found an abundance of 
sRNA species that were co-enriched with SVs and were resistant to RNase degradation. The 5′ -fragment 
of tRNAGlu that was most abundant in cholinergic T. californica SVs was the second most abundant 
species of sRNA found in SVs isolated from the mouse brain. Other species of sRNAs were found to be 
abundant in mouse CNS vesicles, including known miRNAs, and most abundantly, 5′ RNA fragments 
of the Ro ribonucleoprotein associated Y1 RNA (RNY1)15. Together these observations not only support 
the idea that sRNAs are present within SVs, they also suggest that these sRNAs play key roles regulating 
local protein synthesis at the synapse.
Results
Cholinergic vesicles isolated from the electric organ contain RNA. We isolated synaptic vesicles 
from the electric organ of the Pacific ray T. californica in order to provide an abundant, homogenous 
preparation of cholinergic SVs14. We chose a freeze grinding method of isolation that has been shown 
by others to retain more of the SV neurotransmitter content while offering a similar SV enrichment 
(~20 fold) as other isolation procedures16,17. In addition, we wanted to isolate SVs residing within classic 
synaptosomal boutons as well as those present at less structured synaptic varicosities. SVs were collected 
from the middle of the 0.6 M (1.07 g/ml density) sucrose gradient layer, well above the 1.2 M (1.17 g/
ml) sucrose layer used to isolate exosomes18,19 or detect exosome markers20,21. The size of the vesicles we 
isolated averaged ~80 nm (Fig. 1a), larger than SVs within the vertebrate CNS (~40 nm)22 or SVs found 
at vertebrate neuromuscular junctions (~50 nm)23,24, but normal for vesicles from this preparation25. As 
further verification that the isolated vesicles were neuronal in origin, we found by western blot analysis 
that the synaptic vesicle marker synaptophysin26 was enriched during isolation and that the vesicular 
acetylcholine transporter (VAChT)27 was present in the final preparation (Fig. 1b; Supplemental Fig. 1).
We hypothesized that, in addition to neurotransmitter, SVs might contain RNA. To test this hypoth-
esis we extracted RNA from the SV enriched preparation using a TRIzol extraction method and found 
abundant small molecule RNAs (Fig.  1c). The cytoplasm of presynaptic terminals likely contains RNA 
molecules that might co-enrich with the SVs. In order to test whether the sRNAs were exogenous to 
or resided within the SVs we hypothesized that the vesicle membranes would provide protection from 
RNase degradation, thus allowing us to separate the cytoplasmic associated RNA from any vesicular 
protected RNA. We tested the preparation under five conditions. In the presence of high pH buffer (pH 
10—known to disrupt RNA secondary and tertiary structure28) we observed no difference between the 
RNA isolated from the pH 7.4 SV preparations and the RNA isolated from the pH 10 SV preparation. 
We next chose, along with high pH, to add membrane detergent (DM; n-Decyl-β -D-Maltopyranoside) 
to disrupt the SV membranes without denaturing proteins29. Once again in the presence of pH 10 and 
DM we found no difference between the RNA we isolated from the untreated SV preparation. Next we 
added RNase to the SVs. In the presence of RNase we found a substantial (~20 fold; Supplemental Table 
1) reduction in RNA, suggesting that exogenous RNA does co-enrich with SVs. After RNase treatment 
a specific band of sRNAs of approximately ~32 nucleotide (nt) persisted. It was only when we combined 
pH 10, DM, and RNAse that we observed degradation of the ~32 nt band (Fig.1c).
We have previously used a single-vesicle imaging approach to study the co-localization of multi-
ple types of vesicular transporters to single vesicles in the cholinergic SV preparation30,31. As an initial 
step to verify that the sRNAs not degraded by RNase resided within cholinergic synaptic vesicles, and 
were not the result of RNA co-enriching with the SVs during the isolation procedure, we triple labe-
led isolated SVs in the presence of RNase (Fig. 1d). Isolated SVs were labeled by immunofluorescence 
with a polyclonal antibody against VAChT, the nucleic acid dye SYTO12, and the membrane steryl dye 
FM4–64. Because SVs are smaller than the diffraction limit, cholinergic vesicles were identified as small 
diffraction-limited dots visible in the FM4–64 channel that co-labeled for VAChT. Almost all cholinergic 
SVs co-labeled for RNA (96.1%; N = 307).
Cholinergic vesicles isolated from the electric organ contain tRNA fragments. We sequenced 
the RNase resistant cholinergic SV’s sRNA. As a further step beyond size-and density-based purification 
methods, magnetic beads with conjugated antibodies against VAChT were used in the purification pro-
cedure (Supplemental Fig. 1)19,32. SV non-luminal RNA was removed by treatment with RNase before 
luminal RNA was extracted by TRIzol. Five primary sequences with slight variations of length dominated 
the next generation sequencing reads, accounting for 60% of the total reads (Table 1). The most abun-
dant primary sequence was that of a 5′ fragment of a tRNAGlu with the anticodon CUC (tRNAGluCUC) 
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that is conserved across vertebrates (Fig. 2a), followed by 5′ fragments of two different tRNAs specifying 
glycine (tRNAGlyCCC), a 5′ fragment of tRNA Valine (5′ -tRNAValCAC), and a 5′ fragment of tRNA Lysine 
(tRNALysUUU). Fragments of tRNA, both 5′ and 3′ , are signaling molecules cleaved by the vertebrate 
RNase angiogenin33–35, and are designated 5′ - and 3′ - trfRNAs (for stress-induced tRNA fragment). We 
verified that the 5′ -trfRNAs were not a result of the RNase treatment used in the isolation procedure 
by northern analysis of the most abundant 5′ -trfRNAGlu sequence (Fig.  2b; Supplemental Fig. 2). The 
northerns were conducted three times, each with RNA isolated from SVs prepared from separate fish. 
Only a ~32 nt band was observed in samples of the isolated SVs, pH 10 treated SVs, membrane detergent 
(DM) treated SVs, and RNase treated SVs. RNAs from the SV sample treated with pH 10-DM-RNase 
Figure 1. Cholinergic SVs from the electric organ of Torpedo californica contain RNA. (a) Electron 
micrograph of negatively stained SVs isolated and enriched from electroplaque tissue. Sample contains 
abundant ~80 nm vesicles (some marked with arrows). (b) Western-blot analysis of the synaptic vesicles 
during purification. The SV protein synaptophysin was used as a marker during the enrichment. The 
isolation procedure includes the collection of the original slurry (Sl), two centrifugation supernatants and 
pellets (S1, P1 and S2, P2), followed by a sucrose density gradient centrifugation and collection of the 
SV fluffy layer (FL). Further purification using size-exclusion chromatography yields the final, enriched 
sample of SVs (SV). Purified vesicles were tested by immunoblot and found to be positive for the ~60 kD 
vesicle acetylcholine transporter (VAChT). (c) Abundant sRNAs co-enrich with the synaptic vesicles (SV). 
These sRNAs are stable under high pH (pH10), or in the presence of detergent (DM). After addition of 
RNase much of the RNA is degraded; however an RNase resistant ~32 nt band persists (RNase). The RNase 
resistant band of RNA can be degraded in the presence of high pH, detergent, and RNase (pHDR). Bands of 
gel underlined (_) indicate a 20-fold reduction of sample loaded. (d) TIRF microscope images of SVs reveals 
that single SVs contain RNA, as demonstrated by triple-labeling of the SVs with the styryl dye FM4–64, 
VAChT, and the RNA dye SYTO12. Five representative vesicles shown from a total of 307. Scale bar = 1 μ m.
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were degraded, providing further evidence that the 5′ -trfRNAs reside within the cholinergic SVs, and 
are not a product of the RNAse treatment (Fig. 2b).
To test whether the full-length tRNAGluCUC could be found in the presynaptic electric lobe and/
or the postsynaptic electric organ we extracted total RNA from the two tissues for northern anaylsis. 
Full-length tRNAGluCUC and 5′ -trfRNAGlu were found in near equal abundance in the electric organ, 
whereas 5′ -trfRNAGlu was more abundant than tRNAGluCUC in the electric lobe (Fig.  2c; Supplemental 
Fig. 2). We further enriched for tRNA from total RNA preparations using sodium acetate and LiCl 
Sequence NT Copy# Identity
1 UCCCUGGUGGUCUAGUGGUUAGGAUUCGGCGC 32 2988724 5′ -trfRNAGlu
 UCCCUGGUGGUCUAGUGGUUAGGAUUCGGCGCUC 34 475743
UCCCUGGUGGUCUAGUGGUUAGGAUUCGGCGCU 33 402173
UCCCUGGUGGUCUAGUGGUUAGGAUUCGGCG 31 249273
UCCCUGGUGGUCUAGUGGUUAGGAUUCGGC 30 80234
4196147
2 GCAUUGGUGGUUCAGUGGUAGAAUUCUCGCC 31 829169 5′ -trfRNAGly
GCAUUGGUGGUUCAGUGGUAGAAUUCUCGCCU 32 412080
GCAUUGGUGGUUCAGUGGUAGAAUUCUCGCCUG 33 299964
GCAUUGGUGGUUCAGUGGUAGAAUUCUCGCCUGC 34 205669
GCAUUGGUGGUUCAGUGGUAGAAUUCUCGC 30 172506
1919388
3 GCAUCGGUGGUUCAGUGGUAGAAUUCUCGCC 31 200366 5′ -trfRNAGly
GCAUCGGUGGUUCAGUGGUAGAAUUCUCGCCUGC 34 115460
GCAUCGGUGGUUCAGUGGUAGAAUUCUCGCCUG 33 79351
395177
4 GUUUCCGUAGUGUAGUGGUUAUCACGUUCGCC 32 219845 5′ -trfRNAVal
5 GCCCGGAUAGCUCAGUCGGUAGAGCAUCAGAC 32 130889 5′ -trfRNALys
Table 1.  sRNAs identified through next-generation sequencing of affinity purified SVs from the 
electroplaque of T. californica.
Figure 2. Cholinergic vesicles isolated from the electric organ of T. californica contain 5′-tRNA 
fragments. (a) Next-generation sequencing of RNA isolated from RNase treated SVs enriched and affinity 
purified against VAChT reveals that cholinergic SVs contain 5′ fragments of tRNA. The most abundant 
fragment ( 5′ -trfRNAGlu) shown in red mapped onto the complete tRNA glutamate (tRNAGluCUC) shown 
in black. (b) Northern analysis of RNA isolated from SVs verifies that the 5′ -trfRNAGlu sequence was not 
a product of RNase treatment. RNA isolated from SVs purely isolated (SV), at pH10 (pH10), in detergent 
(DM), treated with RNase (RNase), and treated simultaneously with pH10, detergent, and RNase (pHDR). 
Bands of gel underlined (_) indicate a 20-fold reduction of sample loaded. (c) Northern analysis of total 
RNA (TRIzol) and tRNA enriched RNA (LiCl) isolated from the electric lobe (LB) and electric organ (OG) 
of T. californica reveals full length tRNAGluCUC and 5′ -trfRNAGlu were found in near equal abundance in the 
electric organ, whereas 5′ -trfRNAGlu was more abundant than tRNAGluCUC in the electric lobe.
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extraction36, and observed a similar pattern of tRNAGluCUC and 5′ -trfRNAGlu abundance in the tissues 
(Fig. 2c; Supplemental Fig. 2).
5′-trfRNAGlu localizes to axons and presynaptic nerve terminals. To confirm that 5′ -trfRNAs 
are presynaptic SV-associated species, we performed fluorescent in situ hybridization on cryostat sections 
of the T. californica electric organ. Probes for 5′ -trfRNAGlu or the SV transporter VAChT were used in 
association with fluorescently labeled α -Bungarotoxin, a postsynaptic marker for the nicotinic recep-
tors that cover the surface of the electric organ. Nerve axons run perpendicular to the pancake stacked 
electric organ electrocytes before turning 90 degrees and innervating the entire surface of each cell. We 
found that the probe for 5′ -trfRNAGlu, but not a scrambled control probe, labeled the axons and surface 
of the electrocytes in a similar pattern as the presynaptic SV marker VAChT (Fig.  3a,b; Supplemental 
Fig. 3), suggesting that the 5′ -trfRNAGlu is associated with axons and presynaptic nerve terminals rather 
than the postsynaptic electric organ.
Synaptic vesicles isolated from mouse CNS contain RNA. We hypothesized that synaptic vesi-
cles residing in the CNS might also contain sRNAs. To test this, we isolated SVs from the mouse brain of 
Swiss Webster mice. As expected, the mouse brain SVs were ~40 nm in diameter (Fig. 4a) and the syn-
aptic vesicle marker synaptophysin co-purified with SVs during isolation (Fig. 4b; Supplemental Fig. 4). 
Once again, SVs were collected from the middle of the 0.6 M (1.07 g/ml density) sucrose gradient layer, 
well above the 1.2 M (1.17 g/ml) sucrose layer used to isolate exosomes18,19 or detect exosome markers20. 
We treated the mouse SVs with TRIzol and found that the preparation was enriched in sRNAs (Fig. 4c). 
As with the T. californica SVs, we tested the mouse SV RNA under three conditions. We raised the buffer 
to pH10, but saw little difference. Next we added the detergent DM (also at pH10) and observed little 
difference between the RNA we isolated from the SV prep. When we added RNase to the SV prep we had 
a dramatic reduction (~38 fold; Supplemental Table 2) in the amount of total RNA extracted; however, 
two bands of resistant RNA at ~32 nt and ~21 nt remained. These bands appear to be partially degraded 
when we combined pH10, membrane detergent (DM), and RNase (Fig. 4c).
We sequenced the RNase resistant mouse SV sRNA using next generation sequencing. Two classes 
of sequences with slight variations of length dominated the reads, with the top ten sequences account-
ing for 40% of the total reads (Table 2). The most abundant set of sequences mapped to a 5′ fragment 
Figure 3. 5′-trfRNAGlu localize to axons and presynaptic nerve terminals of the electric organ of  
T. californica. (a) Immunohistochemical labeling of 20-micron thick cryostat sections of the electric organ. 
Axons and presynaptic terminals labeled with polyclonal antibodies against VAChT (red). The nicotinic 
acetylcholine receptor rich surface of the electrocyte cells labeled with α -Bungarotoxin (green). (a’) Enlarged 
region from (a), axon marked with white arrow and presynaptic bouton white arrowhead (b) A similar 
pattern of labeling is present within in situ hybridization samples of the same tissue. Axons and presynaptic 
boutons labeled with a probe for 5′ -trfRNAGLU (red), and the surface of the electrocyte cells labeled with 
α -Bungarotoxin (green). (b’) Enlarged region from (b), axon marked with white arrow and presynaptic 
boutons white arrowheads (a’,b’) scale bar = 5 μ m.
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Figure 4. SVs isolated from the mouse CNS contain sRNAs. (a) Electron micrograph image of negatively 
stained vesicles isolated from the mouse CNS. Sample contains abundant ~40 nm vesicles (some marked 
with arrows). (b) Western-blot analysis of the synaptic vesicles during purification. The SV protein 
synaptophysin was used as a marker during isolation. The isolation procedure includes the collection of the 
orginal slurry (Sl), two centrifugation supernatants and pellets (S1, P1 and S2, P2), followed by a sucrose 
density gradient centrifugation and collection of the SV fluffy layer (FL). Further purification using size 
exclusion chromatography yields the final, isolated sample of SVs (SV). (c) Abundant sRNAs co-enrich with 
the synaptic vesicles (SV). These sRNAs are stable under high pH (pH10), or in the presence of detergent 
(DM). After addition of RNase much of the RNA is degraded; however an RNase resistant ~32 nt and lower 
~20 nt band persists (RNase). The RNAse resistant band of RNA can be partially degraded in the presence 
of high pH, detergent, and RNAse (pHDR). (d) Northern analysis of RNA isolated from SVs verifies that 
the 5′ -trfRNAGlu sequence, the second most abundant sequence in mouse CNS SV, was not a product of 
RNase treatment. RNA isolated from SVs purely isolated (SV), at pH10 (pH10), in detergent (DM), treated 
with RNase (RNase), and treated simultaneously with pH10, detergent, and RNase (pHDR). In the mouse 
CNS, both full-length tRNAGluCUC and 5′ -trfRNAGlu co-enrich with the SVs, but only 5′ -trfRNAGlu is resistant 
to RNase treatment. (e) The most abundant species of sRNA in mouse was a 5′ fragment of a Y RNA: Ro-
associated Y1 (RNY1):5′ -fRNY1. Like the 5′ -trfRNAGlu, full length and precursor sequences of RNY1 co-
enrich with the SVs. (c–e) Bands of gel underlined (_) indicate a 20-fold reduction of sample loaded. (f) 
The miRNA and RISC associated protein AGO2 co-enriches with SVs, however it is susceptible to trypsin 
degradation (0–20 minute exposure) indicating it does not reside within the lumen of the SVs. The SV protein 
synaptophysin, which has trypsin cleavage domains residing within the lumen of the SVs, is not degraded.
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of a Y RNA: Ro-associated Y1 (RNY1)15. The 5′ fragment of RNY1 (5′ -fRNY1) is part of the stem 
loop of RNY1, and like the 5′ -trfRNAs, exists as multiple copies of similar length (~32 nt). The second 
most abundant set of sRNAs in the mouse CNS SVs was the most abundant sequence found in the 
T. californica SVs: the 5′ -trfRNAGlu (~32 nt). The third, fourth, seventh, eighth and ninth mapped to 
neuronal associated microRNAs, including miR128, miR99, miR100, miR22, and miR127 (21–22 nt). 
Fragments of other tRNAGlu species accounted for the fifth and sixth most abundant sequences. The fifth 
sequence does not map perfectly to any known mouse genomic sequence for a tRNA, perhaps as a result 
of a splice variation or mouse genomic strain difference, and the sixth most abundant sequence mapped 
to a fragment of tRNAGluTTC. The tenth most abundant sequence mapped to the 5′ -terminal fragment of 
the 28 s ribosomal RNA (20 nt). These nucleotides, along with the last 20 nt of the 5.8 s RNA, form the 
eukaryotic expansion segment known as ES4L, a double-stranded complex of the 60 s ribosomal subunit37.
We verified that the 5′ -trfRNAs were not a result of the RNase treatment used in the isolation pro-
cedure by northern analysis with the 5′ -trfRNAGlu sequence. The northerns were conducted three times, 
each with RNA isolated from a different preparation of mouse SVs. As with the T. californica, the 32 nt 
5′ -trfRNAGlu is present in the mouse SV preparations before RNase treatment (Fig.  4d). Unlike the 
T. californica SV preparation, full-length ~80 nt tRNAGluCUC does appear to associate with synaptic ves-
icles prior to RNase degradation. In addition, we did not see an appreciable decline in signal for the 
5′ -trfRNAGlu after pH 10-DM-RNase treatment (Fig. 4d; Supplemental Fig. 5). We can quantify the num-
ber of 5′ -trfRNAGlu per SV from the mouse CNS using the weight of an average mouse SV (25.6 × 10−18 
g/vesicle)38 and the amount of 5′ -trfRNAGlu detected in our northern analysis. We found that on average, 
15 vesicles per 1000 would contain a 5′ -trfRNAGlu if the sRNAs were evenly distributed (Supplemental 
Fig. 5). In the northern analyses of the 5′ -fRNY1 RNA, multiple sizes representing full length and partial 
fragments of the RNY1 are associated with the SVs before RNAse treatment—ranging from shorter than 
Sequence NT Copy# Identity
1 GGCUGGUCCGAAGGUAGUGAGUUAUCUCAAUU 32 4491149 RNA, Ro-associated Y1
GGCUGGUCCGAAGGUAGUGAGUUAUCUCAAU 31 3921692
GGCUGGUCCGAAGGUAGUGAGUU 23 799788
GGCUGGUCCGAAGGUAGUGAGUUAUCUCA 29 347449
GGCUGGUCCGAAGGUAGUGAGUUAUCUCAA 30 338822
GGCUGGUCCGAAGGUAGUG 19 314918
10213818
2 UCCCUGGUGGUCUAGUGGUUAGGAUUCGGCG 31 2289788 5′ -trfRNAGlu
UCCCUGGUGGUCUAGUGGUUAGGAUUCGGCGC 32 2039321
UCCCUGGUGGUCUAGUGGUUAGGAUUCGGC 30 882725
UCCCUGGUGGUCUAGUGGUUAGGAUU 26 576141
UCCCUGGUGGUCUAGUGGUUAGGAUUCGG 29 333204
6121179
3 UCACAGUGAACCGGUCUCUUU 21 2581783 MIR-128-1
UCACAGUGAACCGGUCUCUUUU 22 1857626
 UCACAGUGAACCGGUCUCUUUUU 23 427156
4866565
4 AACCCGUAGAUCCGAUCUUGU 21 2055063 MIR-99a
 AACCCGUAGAUCCGAUCUUGUG 22 346662
2401725
5 UCCCUGUGGUCUAGUGGUUAGGAUUCGGCG 30 1488662 5′ -trfRNAGlu
6 UCCCACAUGGUCUAGCGGUUAGGAUUCCUGGUU 33 1087820 5′ -trfNAGlu
7 AACCCGUAGAUCCGAACUUGUG 22 545334 MIR-100
AACCCGUAGAUCCGAACUUGU 21 350473
895807
8 AAGCUGCCAGUUGAAGAACUGU 22 716387 MIR-22
9 UCGGAUCCGUCUGAGCUUGG 20 687125 MIR-127
10 CGCGACCUCAGAUCAGACGU 20 609557 rRNA-RNA, 28S ribosomal 5
Table 2.  sRNAs identified through next-generation sequencing of SVs isolated from the mouse CNS.
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30 nt to the full length 112 nt (Fig. 4e; Supplemental Fig. 6). However, only the 32 nt 5′ -fRNY1 is sub-
stantially enriched inside the SV and thus protected from RNase degradation. We found that on average, 
142 vesicles per 1000 would contain a 5′ -fRNY1 if the sRNAs were evenly distributed (Supplemental 
Fig. 6). As with the 5′ -trfRNAGlu, we did not see an appreciable degradation of the 5′ -fRNY1 after pH 
10-DM-RNase treatment. We verified that the RNAse cocktail was capable of degrading all of the sRNA 
in the sample by first isolating the RNase resistant RNA with Trizol followed by a treatment of RNase. 
Once separated from the SV, all of the sRNAs were degraded (Supplemental Fig. 7).
We did not find any complementary sequences to the 20–21 nt miRNAs found within the SVs, sug-
gesting the miRNAs present are single stranded. We tested whether the miRNAs that reside within 
the SVs might be associated with argonaute-2 (AGO2), as a previous study found AGO2 associated 
with enriched SVs13. AGO2 bound to miRNAs can form the minimal RNA-induced silencing complex 
(RISC)39. We found that AGO2 was associated with our SV preparation. To test whether AGO2 resided 
within the SVs, or was associated with the exterior of the SVs, we treated the sample with the protease 
trypsin. We hypothesized that much like the RNase resistant sRNAs, AGO2 would be protected from 
degradation if it resided within the SVs. AGO2 was not protected from degradation, suggesting the 
miRNAs present are not associated with AGO2 (Fig. 4f). To verify that we were not inducing the degra-
dation of the vesicles with the application of trypsin we also tested for the degradation of synaptophysin. 
Synaptophysin can be cleaved by trypsin, but the trypsin cleavage sites reside within the lumen of the 
SVs. Synaptophysin was not degraded in the trypsin treated samples (Fig. 4f). That AGO2 is associated 
with the isolated SVs raised the possibility that some of the RNase and detergent resistant sRNAs might 
be in an AGO2 associated complex. To test that hypothesis we treated SVs with trypsin for 20 minutes, 
followed by trpsin inhibitor and RNase. The sRNAs were resistant to the trypsin treatment (Supplemental 
Fig. 7). As an additional test we treated the SVs with trypsin in association with the membrane detergent 
DM for 20 minutes before addition of trypsin inhibitor and RNase treatment. The RNase resistant sRNAs 
persisted - northerns for both 5′ -fRNY1 and 5′ -trfRNAGlu demonstrated that the sRNAs were not affected 
by prior treatment with trypsin, and the addition of DM had no effect (Supplemental Fig. 7).
What is the structure of 5′-trfRNA? In an effort to gain insight into the molecular mechanism of 
5′ -trfRNAGlu, we examined the predicted structure of 5′ -trfRNAGlu through computational approaches. 
We used RNAfold40 to calculate the optimal secondary structure of the minimum free energy (MFE) 
of the sequence (Fig.  5a). We found that MFE of the optimized secondary structure was − 5.20 kcal/
mol. The free energy of the thermodynamic ensemble was − 5.37 kcal/mol, with a frequency of the MFE 
structure in the ensemble of 76% (Fig. 5a). A similar centroid secondary structure was calculated with 
a MFE of − 5.20 kcal/mol. Based upon this secondary structure we calculated a tertiary structure of the 
5′ -trfRNAGlu using RNACOMPOSER41. Surprisingly, the stem and loop structure determined in this 
manner closely resembled known crystal structures of the tRNA anticodon stem and loop, particularly 
at the anticodon region (Fig. 5d), even though the tRNAGlu anticodon from the full-length tRNA is not 
Figure 5. Tertiary structure of 5′-trfRNAGlu mimics tRNA anticodon stem and loop. (a) RNAfold was 
used to calculate the minimum free energy secondary structure of 5′ -trfRNAGlu. Base-pair probabilities are 
shown in a heat map from 0–1; for non-paired nucleotides, heat map indicates probability of being unpaired. 
(b) The centroid secondary structure is identical to the minimum free energy structure. The heat map shows 
the positional entropy (from 0–1.1). (c) Secondary structure of 5′ -trfRNAGlu showing the pseudo-anticodon 
region in orange. (d) Tertiary structure of 5′ -trfRNAGlu calculated using RNACOMPOSER (red and orange). 
The tertiary structure was aligned in pymol to a known crystal structure of a tRNA, shown in blue (yeast 
tRNAPhe 1ehz) The stem and loop structure determined in this manner closely resembled known crystal 
structures of the tRNA anticodon stem and loop, particularly at the anticodon region (orange). The sequence 
of this pseudo-anticodon is GGU. Both RNAfold and RNACOMPOSER used with default settings.
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present in the 5′ tRNA fragment. The sequence of this pseudo-anticodon is GGU and thus would recog-
nize threonine codons, a codon not present in vertebrate genomes.
Discussion
In this study, we demonstrated that cholinergic SVs isolated from the PNS electroplaque of T. californica 
contain sRNAs (Fig.  1c). Single vesicle imaging of RNase treated SV preparations from T. californica 
demonstrated that membrane bound structures co-labeled with probes for membrane, for cholinergic 
neurotransmitter transporter VAChT, and for RNA (Fig.  1d). We immunopurified T. californica SVs 
using antibodies against VAChT. We then isolated RNase resistant sRNAs from these vesicles. Next gen-
eration sequencing showed that these sRNAs consisted primarily of 5′ -tRNA fragments, with 5′ - trfR-
NAGlu being the most abundant (Table 1). We demonstrated by northern analysis that the 5′ - trfRNAGlu 
was not a byproduct of RNase treatment (Fig.  2b), and that it exists as both a full-length tRNAGluCUC 
and a 5′ -trfRNAGlu in the T. californica PNS, and in the electric lobe, the location within the CNS of 
the cell bodies of the electromotor neurons (Fig. 2c). In addition, we demonstrated by northern analysis 
that the signal representing 5′ - trfRNAGlu in the T. californica SV preparation could only be reduced 
below detectable levels in the presence of detergent, high pH, and RNase (Fig. 2b), suggesting that this 
RNA resides within the vesicles. In situ hybridization of the 5′ - trfRNAGlu sequence was consistent with 
immunohistochemical labeling of the SV marker VAChT in cryostat sections of the T. californica electric 
organ (Fig. 3a,b).
We extended our findings to heterogeneous SVs isolated from the mouse brain. We found that these 
mouse brain SVs also contain sRNAs, the most abundant of which is a 5′ fragment of the RO associated 
Y1 RNA, we term 5′ -fRNY1 (Table 2). The second most abundant sRNA sequence in SVs isolated from 
the mouse brain is the 5′ - trfRNAGlu. We demonstrated by northern analysis that the 5′ -fRNY1 and the 
5′ - trfRNAGlu were not a byproduct of RNase treatment (Fig.  4d,e), i.e. we found that precursors for 
both fragments exist, but are degraded by RNase treatment, suggesting they do not reside within the SV 
lumens. One potential interpretation for the presence of the precursors in association with the SVs is 
that the presynaptic terminal is a site of cytoplasmic maturation and cleavage of SV sRNAs. Finally, we 
demonstrated by northern analysis that the signals representing the 5′ -fRNY1 and 5′ - trfRNAGlu in the 
mouse CNS SV preparation were RNase resistant (Fig. 4d,e)—even if the SVs were treated with trypsin 
(Supplemental Fig. 7). We do not have an explanation for the persistence of the mouse sRNAs in deter-
gent and RNase compared to the T. californica sRNAs sensitivity to the same treatment. The smaller 
size of the mouse SVs may make them less soluble in detergent, or the sRNAs are in a trypsin resistant 
complex in the mouse SVs.
The most abundant sRNA present in T. californica SVs, as well as a large percentage of the sRNAs pres-
ent in mouse SVs (second, fifth and sixth most abundant), were previously identified as stress-induced 
tRNA fragments (Tables 1 and 2). Two pathways are known to produce these fragments in vertebrates. 
5′ -trfRNATyr arises by induced RNA pol III transcription in response to H2O242. A second pathway for the 
production of 5′ -trfRNAs is by the stress-induced RNase angiogenin33,34,43. Angiogenin has been shown 
to be involved in the fragmentation of tRNAGluCUC into 5′ -trfRNAGlu in airway epithelial cells after viral 
infection and induce stress granule formation and suppress protein translation in a miRNA and siRNA 
independent manner35. Whether a similar mechanism occurs at the synapse, or in other tissues shown 
to be enriched in 5′ -trfRNAGlu and 5′ -trfRNAGly is not known44. We calculated a tertiary structure of the 
5′ -trfRNAGlu using RNACOMPOSER41, which predicted a stem and loop structure that closely resem-
bled known crystal structures of the tRNA anticodon stem and loop (Fig. 5d). If 5′ -trfRNAGlu does alter 
translation in a miRNA and small interfering RNA (siRNA) independent manner, perhaps it does so by 
directly interacting with the protein translation machinery by mimicking the anti-codon stem loop of 
a tRNA.
In this paper we focused on the isolation and localization of sRNAs isolated from SVs of two different 
organisms, the PNS of T. californica and the CNS of mouse. The most abundant sequences of sRNAs 
isolated and sequenced were over 30 nt; however, we did isolate and sequence miRNAs in the 20–21 nt 
range, including miR128, miR99a, miR100, miR22, and miR127. The most abundant miRNA, and the 
third most abundant class of sequences was miR128, a miRNA important for neuronal development, 
synaptogenesis, and post-mitotic neuronal functioning45. Members of the miR-99 family (miR99a, and 
miR100, the fourth and seventh most abundant mouse sRNAs) are miRNAs that have been shown to 
co-enrich with polyribosomes in mammalian neurons, and regulate the mammalian target of rapamycin 
(mTOR) pathway46. miR22, the eighth most abundant mouse sRNA, is important for cerebellar devel-
opment, and in adults has been shown to protect neurons from neurodegeneration, and is down reg-
ulated in both Huntington’s and Alzheimer’s disease47. miR127, along with a cluster of miRNAs found 
on chromosome14q32, is maternally expressed, and the down regulation of miRNAs within this cluster 
(including miR127) has been linked to schizophrenia48. The mechanism by which miRNAs are taken in 
at the synapse is not known. However, a previous study has demonstrated that miR99a is released from 
synaptosomes in an activity and calcium dependent manner, consistent with the release from SVs, and 
synthetic miRNAs were taken up by synaptosomes via an unspecified endocytic pathway13.
Long-term changes in synaptic plasticity require protein synthesis, the local dendritic regulation of 
which is still an active area of research6–9. One common, and critical component of every model of 
local protein synthesis is the role activity plays in the up-regulation and down-regulation of translation. 
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Activity at a local synapse is driven by the presynaptic fusion of synaptic vesicles with the plasma mem-
brane, and the subsequent release of the contents residing within the SV lumen. Currently most of 
our understanding of SV content release has focused on small molecule neurotransmitters that rapidly 
bind metabotropic and ionotropic receptors leading to near instantaneous changes in target membrane 
excitability. Given the immense specificity and wide ranging effects that sRNAs can exert on transcrip-
tion and translation10,49,50, the precise molecular control with which SVs link presynaptic activity to SV 
content release, and the developmental precision with which the pre and postsynaptic apparatus are 
spatially aligned at every type of synapse, the addition of sRNAs to the list of molecules released by SVs 
during exocytosis, and/or possibly taken up by SVs during endocytosis, is both powerful and exciting. 
It provides the potential for a direct means of controlling translation locally, which may prove at least as 
important as the proposed calcium induced mechanisms for controlling translation.
Materials and Methods
Isolation and enrichment of synaptic vesicles. Methods were adapted from Ohsawa51. Three prepa-
rations of electric organ with tissue from 3 separate Torpedo californica fish (2 female, 1 male), and three 
preparations of mouse brains (approximately 50 mouse brains of both male and female per each prepa-
ration) were used during these studies. A Spex Freezer Mill 6800 (Spex Sample Prep; Metuchen, NJ) was 
cooled to − 180 °C and ~25 g of frozen electric organ from an individual (Aquatic Research Consultants; 
San Pedro, CA) or 25 g frozen Swiss Webster mouse brains (BioChemed Services, Winchester, V.A.) was 
ground with 25 g of frozen buffer pellets (320 mM Sucrose, 10 mM TRIS-Cl, pH 7.4) (Sigma-Aldrich; St. 
Louis, MO). The resulting powder of buffer and electric organ/brain was warmed to 4 °C with 50 ml of 
buffer solution (320 mM Sucrose, 10 mM Tris-Cl, pH 7.4, 4 °C). The resulting slurry (100 ml) was cen-
trifuged at 20,000 rpm for 10 minutes (Beckman Coulter JA-20 rotor—Avanti J25 centrifuge) (Beckman 
Coulter; Brea, CA). The resulting supernatant was centrifuged at 34,000 rpm for 40 minutes (70ti rotor 
- Optima X80; Beckman). The supernatant was then loaded onto a 4 ml/4 ml 0.6 M/1.2 M sucrose step 
gradient (10 mM Tris-Cl, pH 7.4), then centrifuged at 48,000 rpm for 2 hours (70ti rotor - Optima X80). 
The 4 ml 0.6 M (1.07 g/ml density) sucrose fluffy layer, enriched in vesicles, was collected. Heavier densi-
ties and pellet (> 0.6 M sucrose), known to be enriched in exosomes, were discarded18,20. A 2 ml sample 
of enriched vesicles was filtered using a 0.22 μ m spin column (Spin-x, Corning; Corning, NY) to remove 
any large debris. The filtrate was injected into a Pharmacia LC500 plus FPLC (GE Healthcare, Fairfield, 
CT) and run through a 25 cm 4% agarose bead column (Bioscience Beads; West Warwick, RI). Separate 
bead columns were prepared for electric organ and mouse brains to ensure no contamination. The FPLC 
was eluted with a buffer solution PBS, pH 7.4 at a flow rate of 1.0 ml/min. The second major peak was 
collected, and the vesicles concentrated to a protein concentration of 5 mg/mL (measured by Bradford 
Assay)(Bio-Rad Laboratories, Inc.; Hercules, CA) using a Stirred Cell apparatus with a 100 kDa filter 
(PLHK02510; Millipore, Billerica, MS).
Electron microscopy. Negative stain of isolated synaptic vesicles of T. californica and mouse are 
conducted following Jahn and Maycox22 . Briefly, A 5 μ l sample of enriched synaptic vesicles (further 
concentrated to 20 mg/ml with Pierce concentrator, PES, 100 K MWCO (88503, Thermo Scientific) as 
determined by Bradford assay was pipetted onto a slot grid. Excess sample was removed by filter paper, 
and the grid was briefly washed in 12 mM sodium phosphate buffer, followed by 2 s staining with uranyl 
acetate (Ted Pella; Redding, CA), followed by another wash22. The slot grid was viewed with a JEOL 1200 
JEOL Ltd., Akishima-Shi, TKY Japan) operated at 100 kV. Image was collected at 50,000 × magnification 
on a bottom-mounted 3072 × 3072, slow scan, lens-coupled CCD camera SIA 15C (SIA; Dulith, GA).
Western blots. Synaptic vesicle lysates were loaded on to a 4–20% SDS-PAGE gel (456–9034; BioRad) 
and blotted using standard protocols. All gel lanes were loaded with equal volume (3 μ l) of sample. 
Primary antibodies against synaptophysin (1:1000; MAB5258; EMD Millipore, Billerica, MA), AGO2 
(1:1000; ab186733; Abcam, Cambridge, England), VAChT (1:1000; ab68986; Abcam), 58 K (1:1000; 
ab19072; Abcam), and Calnexin (1:1000; ab22595; Abcam). Secondary antibodies were HRP-conjugated 
goat-anti rabbit (1:2000; 2–348; EMD Millipore), rabbit anti-goat (1:2000; 6020–05, Southern Biotech; 
Birmingham, AL), and goat-anti mouse (1:2000; ab5879; Abcam). Visualization of blots was conducted 
with ECL Prime (RPN2232; GE Healthcare) according to manufacturer’s instructions. Chemiluminescence 
was quantified using a Chemicdoc XRS + Imager with Imagelab software (BioRad).
Synaptic vesicle RNA isolation and tRNA isolation. SVs were isolated and concentrated as 
described above. For each assay, 1 preparation of vesicles was utilized and split into 5 equal samples. Each 
sample consisted of 3 × 50 μ l of SVs (5 mg/ml) in PBS (80 mM Na2HPO4 and 25 mM NaH2PO4, 100 mM 
NaCl pH 7.4; Sigma). The 5 parallel treatments conducted on the SV preparations were: 1) addition of 
50 μ l PBS, pH 7.4, 2) addition of 50 μ l PBS pH 11 (adjusted with NaOH; Sigma), 3) addition of 50 μ l PBS 
pH 11 and 100 mM membrane detergent DM (n-Decyl-β -D-Maltopyranoside, D322; Anatrace, Maumee, 
OH), 4) addition of 50 μ l PBS pH 7.4 with 1 μ l RNase cocktail as instructed (RNase A (500 U/ml) and 
RNase T1 (20,000 U/ml), AM2286; Ambion/Life Technologies), and finally 5) addition of 50 μ l com-
bined pH 11, DM, and RNAse treatments. RNA was extracted after the treatments using 900 μ l TRIzol 
(Invitrogen/Life Technologies) followed by 200 μ l chloroform and 400 μ l isopropanol (EMD Millipore), 
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with a final precipitation by 75% ethanol. The total SV RNA was resuspended in 6 μ l of DI water, and the 
three samples of each treatment were quantified—Supplemental Tables show combined results.
RNA concentration was determined using QuantiFluor RNA System (E3310, Promega, Madison, WI) 
and Quantus Fluorometer (E6150, Promega). Briefly, 1 μ l of isolated RNA is dissolved for 5 minutes in 
199 μ l of Master solution (20X TE Buffer, DI water, and QuantiFluor RNA dye); the solution was then 
read in the Quantus Fluorometer.
To isolate total RNA from the electric lobe (CNS) and electric organ (PNS) of T. californica, 100 mg 
of tissue of each organ was dissected and ground with silica beads before RNA extraction by TRIzol 
(described above). For further enrichment of sRNA and tRNA, samples of total RNA were resuspended 
in 300 μ l of 10 mM sodium acetate (Sigma-Aldrich) pH 4.5 at 4 °C, and mixed with 30 μ l of 8 M LiCl 
(Sigma-Aldrich). After centrifugation at 15,000 g, 4 °C, the tRNA and sRNA is collected from the result-
ing supernatant.
Fluorescent immunohistochemical labeling of isolated synaptic vesicles and TIRF imaging of 
single vesicles. Isolated SVs were passed through a 0.22 μ m spin column, and 100 μ l of synaptic vesi-
cles (1 mg/ml) were transferred into 300 μ l PBS (pH 7.4), and labeled with one round of primary and sec-
ondary antibody following the procedure52. Briefly, the vesicles were incubated for overnight with 1 μ g of 
VAChT antibody in 4 °C, incubated for 30 min with 20 μ l anti-rabbit IgG beads (Sigma-Aldrich), briefly 
centrifuged, and the vesicle containing supernatant was then incubated with 0.5 μ g goat anti-rabbit sec-
ondary antibody labeled with Pacific Blue (P-10994, Life Technologies) for 4 hours before finally being 
incubated with 20 μ l anti-goat IgG beads (Sigma-Aldrich). The beads were pelleted and the supernatant 
collected for imaging. SVs were incubated in RNase cocktail for 30 minutes.
FM4–6453 and SYTO 12 (S7574; Life Technologies) were added to the labeled vesicles (final concen-
tration 1 μ M), and the samples were settled on a glass bottom culture dish (MatTek P35G-1.5–20-C; 
Ashland, MA) for at least 1 hour. Settled vesicles were imaged with a Zeiss Axio Observer Z1 Microscope 
with TIRF slider, 100X TIRF objective (NA 1.45). Images were acquired using AxioVision (Carl Zeiss; 
Oberkochen, Germany). Three separate images from each field were taken using laser lines and filter 
cubes paired to eliminate fluorescent cross talk between the dyes: laser line 401 with filter cube 73 HE 
was used for Pacific Blue, laser line 488 with filter cube 38 HE was used for SYTO 12, and laser line 561 
with filter cube 74 HE was used for FM 4–64. Images were collected with a Roper S/W PVCAM EMCCD 
camera and analyzed using ImageJ (NIH, Bethesda, MA) software. Suitable spots detected in the FM4–64 
channel were marked. The other channels were then quantified for label.
RNA gels and northern blots. Electrophoresis and blotting are previously described36. Denatured 
RNA samples were run through 10% TBE Urea precast gel (BioRad, 456–6033). Because of resulting sam-
ple differences in yield between non-RNAse treated and RNAse treated SV RNA preparations, gel lanes 
loaded with non-RNase treated samples were reduced by ~20-fold to match the amount loaded in the 
RNase treated lanes as described in figure legends and documented in Supplemental Materials. Northern 
blots were conducted in triplicate, in order to reduce bias from any single preparation, each northern was 
conducted on RNA isolated from a single fish. For mouse brain SVs, three separate preparations of SV 
RNAs were isolated in order to perform northerns in triplicate. Northern blots were transferred to Zeta 
Probe Blotting Membrane (BioRad, 162–0153) in 1xTBE buffer at 20 V for 90 min. The membrane was 
rinsed with 5xSSC buffer and RNAs were crosslinked to the membrane using a Stratalink UV crosslinker 
(auto setting). The membrane was incubated in a hybridization tube with 15 ml of prehybridization buffer 
at 42 °C for 3 or more hours. 50 pmol of oligo was radioactively labeled using 300 μ Ci [gamma32-P] ATP 
(NEG502A; Perkin Elmer; Waltham, MA) and T4 Polynucleotide Kinase and the signal was detected by 
autoradiography. Denatured probe (heated at 95 °C for 5 min and chilled on ice) was added to the hybrid-
ization tube, and incubated at 42 °C overnight. The membrane was washed with 10 ml 2xSSC/0.1% SDS 
and then with 100 ml 0.2xSSC/0.1% SDS at room temperature for 5 min, respectively. The membrane was 
washed at 42 °C with 100 ml 0.2xSSC/0.1% SDS for 30 min and then at 68 °C with 100 ml 0/1xSSC/0.1% 
SDS for 30 min. The membrane was dried and then exposed to a storage phosphorplate (GE Healthcare) 
for 16 h before being scanned with a Typhoon Trio Variable Mode Imager (GE Healthcare) and quanti-
fied based upon binding of probe to positive control loaded sample of known quantity using ImageQuant 
TL software (GE Healthcare).
20x SSC buffer: 3 M sodium chloride, 300 mM sodium citrate. Prehybridization buffer: 0.75 M 
NaCl, 50 mM NaPO4, 5 mM EDTA, 1%SDS, 50% formamide, 0.2% BSA, 0.2% polyvinylpyrollidone 40, 
0.2% Ficoll 400 (Sigma)
trfRNAGlu—probe 5′ - CGCCGAATCCTAACCACTAGCCACCA
trfRNAGlu—positive control in vitro transcription
5′ -TAATACGACTCACTATAGGTCCCTGGTGGTCTAGTGGTTAGGATTCGGCGC
5′ -GCGCCGAATCCTAACCACTAGACCACCAGGGACCTATAGTGAGTCGTATTA
Ro Y1—probe 5′ -AACTCACTACCTTCGGACCAGCC
Ro Y1—positive control in vitro transcription
5′ -TAATACGACTCACTATAGGGGCTGGTCCGAAGGTAGTGAGTT
5′ - AACTCACTACCTTCGGACCAGCCCCTATAGTGAGTCGTATTA
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RNA isolation and sequencing. SVs from T. californica and mouse whole brain were isolated and 
treated with RNAse cocktail (Ambion/Life Technologies) as described above. As a further enrichment, 
SVs from T. californica were affinity enriched using dynabeads (100.07D; Dynabeads; Invitrogen/ Life 
Technologies) with VAChT antibody19,32. The total RNA was extracted following the TRIzol procedure 
described above. Library preparation and sequencing were performed by the Genomic Sequencing and 
Analysis Facility at the University of Texas, Austin. The samples were prepared for sequencing using the 
TruSeq small RNA sample preparation kit (Illumina; San Diego, CA). Single-end reads (100 bp) were 
sequenced on an Illumina HiSeq 2500(Illumina).
trfRNA in situ hybridization. For in situ hybridization (ISH), frozen T. californica electo-
plaque was cryosectioned (30–40 μ m) and mounted onto Superfrost Plus slides (VWR, Radnor, PA). 
Fluorescein-labeled anti-sense morpholino oligomer probe matching coding 5′ -trfRNAGLU was synthe-
sized from Gene Tools (Philomath, OR). Control fluorescein-labeled anti-sense cRNA probes matching 
coding 5′ -trfRNAGLU and scrambled were synthesized from IDT (Coralville, IA). Probes were hybridized 
to sections as previously described54, with minor modifications in amplification strategy. Following over-
night hybridization, slides were incubated with alkaline phosphatase conjugated anti-fluorescein antibody 
(1:5000; 11426338910; Roche Life Sciences, Indianapolis, IN) for overnight at 4 °C. Tissues were washed 
and incubated in Fast Red (11496549001; Roche Life Sciences) according to manufacturer’s instructions 
for overnight at 4 °C in dark. Confocal images were captured with a Zeiss 780 Structure Illumination 
microscope (Zeiss, Germany). Sequences used for probe generation are listed below.
trfRNAGlu Morpholino: 5′ - GCCGAATCCTAACCACTAGACCACC-fluoroscein
trfRNAGlu DNA control: 5′ - GCCGAATCCTAACCACTAGACCACC-fluoroscein
trfRNAGlu DNA scramble: 5′ - CCCGAATCGTAACGACTAGAGCAGC-fluoroscein
Trypsin sensitivity. AGO2/synaptophysin Westerns: SVs were isolated and concentrated as described 
above. One preparation of vesicles was split into 10 equal samples. Each sample consisted of 5 μ l of SVs 
(6 mg/ml) in PBS, pH 7.4. Paired samples were treating in the following manner: no Trypsin treatment, 
2 μ l Trypsin (T1426, 10 mg/ml; Sigma-Aldrich) treated for 5 mins, 10 mins, 20 mins or 30 mins. Westerns 
were conducted using antibodies against synaptophysin or AGO2.
SV RNA sensitivity to Trypsin: SVs were isolated and concentrated as described above. For each assay, 
1 preparation of vesicles was utilized, and split into 4 equal samples of 50 μ l. Each sample consisted of 
SVs (6 mg/ml) in PBS (80 mM Na2HPO4 and 25 mM NaH2PO4, 100 mM NaCl), pH 7.4. The 4 parallel 
treatments conducted on the SV preparations were: 1) addition of 50 μ l PBS, pH 7.4, 2) addition of 
50 μ l PBS pH 7.4 and 0.5 μ l Trypsin (T1426,10 mg/ml; Sigma-Aldrich) for 20 minutes, 3) addition of 
50 μ l PBS pH 7.4 and 0.5 μ l Trypsin for 20 min, followed by 5 μ l Trypsin Inhibitor (T9128, 6.5 mg/10 ml, 
Sigma-Aldrich) and 1 μ l RNAse for 30 min., 4) addition of 50 μ l combined Trypsin, 200 mM DM for 
20 min, followed by 5 μ l Trypsin Inhibitor and RNAse treatment for 30 minutes. RNA was extracted after 
the treatments and quantified as described above.
Prediction of 5′-trfRNAGlu structure. The secondary structure of the 5′ -trfRNAGLU was predicted 
using the default settings of RNAfold40 (ViennaRNA Package 2.0; Theoretical Biochemistry Group, 
University of Vienna Wien, Austria). The resulting secondary structure was used to calculate a predicted 
tertiary structure using the default settings for RNACOMPOSER41 (Institute of Computing Science, 
Poznan University of Technology, Poznan Poland). Visualization of the structure was conducted using 
the MacPymol Molecular Graphics System, Version 1.7.4 (Schrödinger, LLC; Cambridge, MA) running 
on a Mac Pro with OS 10.9.5 (Apple; Cupertino, CA).
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